

Is Papaverine still in shortage in 2026? Get the latest update on supply, pricing, and what patients can do to find Papaverine when it's hard to get.
If you rely on Papaverine — whether for vascular spasms, smooth muscle conditions, or as part of an erectile dysfunction treatment like Trimix — you may have run into supply problems. Papaverine has a history of intermittent shortages, and in 2026, many patients are still finding it difficult to fill their prescriptions at their regular pharmacy.
Here's what's happening with Papaverine supply, what it costs, and what you can do right now.
Papaverine injection has experienced periodic supply disruptions over the past several years. ASHP (American Society of Health-System Pharmacists) tracked a notable shortage in 2017, when American Regent — one of the primary manufacturers — experienced supply issues without providing a specific reason.
As of early 2026, Papaverine is not in a formal FDA-listed nationwide shortage. However, that doesn't mean it's easy to find. The reality on the ground is more nuanced:
The bottom line: even without a formal shortage declaration, Papaverine can be genuinely hard to find at any given moment.
Several structural factors make Papaverine's supply chain fragile:
For a deeper dive into these factors, see our article on why Papaverine is so hard to find.
Papaverine is a generic medication, but "generic" doesn't always mean "cheap" — especially for injectable drugs with limited competition.
Insurance coverage varies widely. When Papaverine is administered in a hospital or surgical setting, it's usually covered under your medical benefit. For outpatient use — especially for erectile dysfunction — coverage is less predictable. Many insurers exclude ED treatments entirely.
For tips on reducing your costs, read our guide on how to save money on Papaverine.
While no new formulations of Papaverine have launched recently, patients have more tools than ever to navigate supply challenges:
If you need Papaverine today, here's your action plan:
For a detailed walkthrough, check out our article on how to find Papaverine in stock near you.
Papaverine's supply situation in 2026 is best described as "available but unpredictable." It's not in a formal shortage, but the combination of limited manufacturers, niche demand, and injectable production challenges means finding it can require some legwork. The key is to plan ahead, use tools like Medfinder, and maintain an open conversation with your prescriber about backup plans.
Providers can learn more about the supply landscape in our companion article: Papaverine shortage — what providers and prescribers need to know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.